VIPoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{VIPoma}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. {{CMG}} ==Overview== ==Ot..." |
No edit summary |
||
Line 12: | Line 12: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 14:34, 30 August 2015
VIPoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
VIPoma other imaging findings On the Web |
American Roentgen Ray Society Images of VIPoma other imaging findings |
Risk calculators and risk factors for VIPoma other imaging findings |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Other Imaging Findings
Somatostatin receptor scintigraphy is used to localise the tumor, which is usually metastatic at presentation.